Athletes can feel the relief a substance gives them long before they can see what it costs. A composite case of cannabis use in a track athlete shows how to assess both.
|Slideshows|January 8, 2020
Psychiatric Sequelae of Pandemics
Author(s)Nidal Moukaddam, MD, PhD
Psychiatrists are likely to encounter patients with depression, anxiety, and paranoia related to communicable diseases and pandemics. Following is a summary of memorable epidemics/pandemics.
Advertisement
Advertisement
Related to this article
Seaport begins phase 2a trial of GlyphAgo for generalized anxiety disorder with sleep disturbance, testing liver-sparing agomelatine dosing and tracking sleep, anxiety outcomes.
Advertisement
Advertisement
Trending on Psychiatric Times
1
Moving Away From Treatment-Resistant Depression and Toward Difficult-to-Treat Depression
2
The New, Impending Adult ADHD Guidelines
3
Reframing “Treatment-Resistant” as “Difficult-To-Treat”
4
Relief Is Not Free: A Case Study of Athlete Cannabis Use
5